Kim YC - Search Results

1

Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.

Kim YC, Lee JH, Kim SH, Lee MG. Kim YC, et al. Among authors: kim sh. Antimicrob Agents Chemother. 2005 Jun;49(6):2528-32. doi: 10.1128/AAC.49.6.2528-2532.2005. Antimicrob Agents Chemother. 2005. PMID: 15917564 Free PMC article.

2

Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.

Shin JH, Choi KY, Kim YC, Lee MG. Shin JH, et al. Among authors: kim yc. Antimicrob Agents Chemother. 2004 May;48(5):1756-62. doi: 10.1128/AAC.48.5.1756-1762.2004. Antimicrob Agents Chemother. 2004. PMID: 15105131 Free PMC article.

3

Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin.

Kim YC, Kwon JW, Kim WB, Lee I, Lee MG. Kim YC, et al. Among authors: kim wb. J Pharm Sci. 2004 Sep;93(9):2374-87. doi: 10.1002/jps.20144. J Pharm Sci. 2004. PMID: 15295797

4

Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.

Lee JH, Kim YC, Kwon JW, Kim WB, Lee MG. Lee JH, et al. Among authors: kim yc, kim wb. Int J Pharm. 2005 May 30;296(1-2):94-102. doi: 10.1016/j.ijpharm.2005.03.006. Epub 2005 Apr 15. Int J Pharm. 2005. PMID: 15885460

5

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats.

Kim YC, Shim HJ, Lee JH, Kim SH, Kwon JW, Kim WB, Lee MG. Kim YC, et al. Among authors: kim sh, kim wb. Biopharm Drug Dispos. 2005 Sep;26(6):233-41. doi: 10.1002/bdd.453. Biopharm Drug Dispos. 2005. PMID: 15926192

6

Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.

Shim HJ, Kim YC, Lee JH, Kwon JW, Kim WB, Kim YG, Kim SH, Lee MG. Shim HJ, et al. Among authors: kim sh, kim yc, kim wb, kim yg. Biopharm Drug Dispos. 2005 Oct;26(7):269-77. doi: 10.1002/bdd.455. Biopharm Drug Dispos. 2005. PMID: 15991256

7

Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin.

Kim YC, Oh EY, Kim SH, Lee MG. Kim YC, et al. Among authors: kim sh. Biopharm Drug Dispos. 2005 Nov;26(8):371-8. doi: 10.1002/bdd.467. Biopharm Drug Dispos. 2005. PMID: 16094676

8

Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin.

Kim YC, Oh EY, Kim SH, Lee MG. Kim YC, et al. Among authors: kim sh. Biopharm Drug Dispos. 2006 Mar;27(2):85-92. doi: 10.1002/bdd.484. Biopharm Drug Dispos. 2006. PMID: 16312011

9

Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.

Kim YC, Kang HE, Lee MG. Kim YC, et al. Biopharm Drug Dispos. 2008 Jan;29(1):51-61. doi: 10.1002/bdd.591. Biopharm Drug Dispos. 2008. PMID: 18022993

10

Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic, in rats.

Lee JH, Kim YC, Kwon JW, Kim WB, Lee MG. Lee JH, et al. Among authors: kim yc, kim wb. Res Commun Mol Pathol Pharmacol. 2005;117-118:179-87. Res Commun Mol Pathol Pharmacol. 2005. PMID: 18426088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,316 results

Search Page

Filters